A study has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal type of brain cancer.
It is often administered in addition to chemotherapy and can be given to glioblastoma patients to reduce cerebral edema that comes after surgery and radiation. But despite its widespread use ...